Print

Dr. Rich Bridges is a Professor of Pharmacology & Toxicology at the The University of Montana in Missoula, MT and founding member of the Montana Neuroscience Institute Foundation. Dr. Bridges’ main research interests are in glutamate transport in the brain. His laboratory research is aimed at understanding how glutamate transport proteins work, how the systems normally function to regulate glutamate levels, and whether or not compromised function may contribute to brain pathology in neurological disorders like stroke, epilepsy, spinal cord injury, ALS or Alzheimer’s disease. He joined me recently to discuss a bit about the history of the MNIF and what the future holds for the organization.

Richard Bridges, PhD

Richard Bridges, PhD

Download 09_01_06_Bridge_Neuroscience_Research.mp3

Download

Dr. Rich Bridges is a Professor of Pharmacology & Toxicology at the The University of Montana in Missoula, MT and founding member of the Montana Neuroscience Institute Foundation. Dr. Bridges’ main research interests are in glutamate transport in the brain. His laboratory research is aimed at understanding how glutamate transport proteins work, how the systems normally function to regulate glutamate levels, and whether or not compromised function may contribute to brain pathology in neurological disorders like stroke, epilepsy, spinal cord injury, ALS or Alzheimer’s disease. He joined me recently to discuss a bit about the history of the MNIF and what the future holds for the organization.

Richard Bridges, PhD

Richard Bridges, PhD

Download 09_01_06_Bridge_Neuroscience_Research.mp3

Download


Read article: http://www.sechrest.com/?p=25.